Author:
Liu Bing-Li,Yang Shao-Ying,Liu Wei,Xue Li-Qiong,Chen Xia,Pan Chun-Ming,Gu Zhao-Hui,Zhan Ming,Zhang Xiao-Mei,Liang Jun,Gao Guan-Qi,Du Wen-Hua,Yuan Guo-Yue,Ying Ru,Zhao Shuang-Xia,Song Huai-Dong
Abstract
BackgroundConvincing evidence has demonstrated the association of TSH receptor (TSHR) with Graves' disease (GD) in the Chinese Han population.ObjectiveThe aim of this study was to identify the causal variants for GD in the region encompassing TSHR by a refining association study.Design and methodsGD patients (1536) and 1516 sex-matched controls were recruited in the first stage, and an additional 3832 GD patients and 3426 sex-matched controls were recruited in the replication stage. Genotyping was performed using Illumina Human660-Quad BeadChips or TaqMan single nucleotide polymorphism (SNP) Genotyping Assays and the Fluidigm EP1 platform.ResultsWhen the results of regression analysis for 74 genotyped SNPs and 922 imputed SNPs in the first-stage cohort were combined, rs179243 and rs3783949 were the probable susceptibility SNPs associated with GD in TSHR. Eleven SNPs, including rs179243 and rs3783949, were selected to further refine the association in the replication study. Finally, rs12101261 and rs179243 were confirmed as independent GD susceptibility variants in the replication and combined populations. Further, we also found that the rate of persistent TSHR autoantibody positivity (pTRAb+) was significantly higher in the GD patients with the susceptible genotypes rs12101261 or rs179243 than in the GD patients carrying the protective genotypes, after the GD patients had been treated for more than 1 year.ConclusionsThese findings indicate that rs12101261 and rs179243 are the possible causal SNPs for GD susceptibility in the TSHR gene and could serve as genetic markers to predict the outcome of pTRAb+ in GD patients.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献